Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.310
-0.110 (-4.55%)
At close: Dec 17, 2025, 4:00 PM EST
2.310
0.00 (0.00%)
Pre-market: Dec 18, 2025, 5:49 AM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $72.89 million as of December 18, 2025. Its market cap has decreased by -69.12% in one year.
Market Cap
72.89M
Enterprise Value
-53.37M
1-Year Change
-69.12%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $72.89M, a decrease of -69.00%. That is a compound annual growth rate of -31.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 76.36M | -59.26% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |